AXL receptor tyrosine kinase as a therapeutic target in NSCLC

Ross A Okimoto,1 Trever G Bivona1,2 1Division of Hematology and Medical Oncology, University of California San Francisco, San Francisco, CA, USA; 2Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA Abstract: The AXL receptor tyrosine kina...

Full description

Saved in:
Bibliographic Details
Main Authors: Okimoto RA, Bivona TG
Format: article
Language:EN
Published: Dove Medical Press 2015
Subjects:
Online Access:https://doaj.org/article/66beb47003984936bec97fbf70841834
Tags: Add Tag
No Tags, Be the first to tag this record!